FEB 25, 2022 3:00 AM PST

Does Exercise Help Prep Tumors for Surgery?

WRITTEN BY: Katie Kokolus

Esophageal cancer, also known as cancer of the food pipe, gullet cancer, or oesophageal cancer, develops in the tube that connects the throat to the stomach. There are two main types of esophageal cancer: squamous cell carcinoma, where cancer begins in the mucosal inner layer of the esophagus, and adenocarcinoma, where cancer begins in the glandular cells that produce mucus and other fluids. 

The American Cancer Society estimates the lifetime risk of esophageal cancer at 1 in 125 in men and 1 in 417 in women. Standard treatment regimens for esophageal cancer include chemotherapy and surgery. Many esophageal cancer patients receive neoadjuvant chemotherapy, given before surgery in an effort to shrink the tumor, increasing the likelihood of successful tumor resection.   

There is growing evidence that exercise helps control tumor growth, but no studies examine a connection between exercise and esophageal cancer. Researchers from Guy’s and St Thomas National Health Service Foundation Trust in London investigated the impact of “prehab”, a moderate-intensity exercise program, including cardiovascular and strength training, undertaken while receiving neoadjuvant chemotherapy. The 21 patients in the intervention group exercised and received neoadjuvant chemotherapy before surgery, while the 19 patients in the control group received standard neoadjuvant chemotherapy prior to surgery. Patients gave blood samples throughout the intervention period for further analysis.

The study, published in The British Journal of Sports Medicine, revealed that patients in the exercise intervention group had higher tumor regression rates (75% regression in the Intervention group versus 36.8% regression in the Control group). The investigators also examined immunological markers in the study participants, and those in the Intervention demonstrated increased levels of T cells, the immune cells responsible for tumor cell killing. 

The results of the study suggest an association between exercise and chemotherapy response in esophageal cancer, likely due, in part, to improved immune function.  The authors acknowledge the small number of patients in the study limits the potential impact of the findings.  Thus, a larger-scale, randomized study to confirm these findings is needed.  In addition, a long-term observational period is necessary to investigate the impact of exercise on survival.   

 

Sources: Cell Metab, Br J Sports Med

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
JAN 24, 2022
Microbiology
Potential Anti-Cancer Bacterium Found in Antarctic Sea Squirt
JAN 24, 2022
Potential Anti-Cancer Bacterium Found in Antarctic Sea Squirt
Some of our best medicine has come from nature, and scientists are always on the lookout for natural products that can b ...
APR 20, 2022
Cancer
"Saturating" the Liver with Chemotherapy to Treat Cancer
APR 20, 2022
"Saturating" the Liver with Chemotherapy to Treat Cancer
Uveal melanoma is a rare type of cancer that grows in the melanin, the dark-colored pigment of the eye. About  ...
APR 28, 2022
Drug Discovery & Development
Keto Molecule Shows Promise for Treating Colorectal Cancer
APR 28, 2022
Keto Molecule Shows Promise for Treating Colorectal Cancer
A molecule produced when on low-carbohydrate ketogenic diets suppresses the growth of colorectal tumors in the lab. The ...
JUN 06, 2022
Immunology
Using Antibodies to Create Potent Cancer Treatments
JUN 06, 2022
Using Antibodies to Create Potent Cancer Treatments
Cancer can arise from a variety of aberrations that cause cells to divide uncontrollably, and form a tumor. The causes o ...
JUN 06, 2022
Drug Discovery & Development
Weight loss Surgery Reduces Cancer Risk and Cancer Deaths
JUN 06, 2022
Weight loss Surgery Reduces Cancer Risk and Cancer Deaths
Weight loss achieved via bariatric surgery among adults with obesity is linked to a lower risk of developing cancer and ...
JUN 20, 2022
Health & Medicine
In a Small Study, Experimental Immunotherapy Drug for Rectal Cancer has a High Success Rate
JUN 20, 2022
In a Small Study, Experimental Immunotherapy Drug for Rectal Cancer has a High Success Rate
The New England Journal of Medicine published results from a small study by researchers at New York’s Memorial Slo ...
Loading Comments...